(TNGX) Tango Therapeutics - Performance -85.3% in 12m
Compare TNGX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-81.93%
#137 in Group
Rel. Strength
3.41%
#7686 in Universe
Total Return 12m
-85.33%
#165 in Group
Total Return 5y
-88.86%
#99 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: TNGX (-85.3%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: TNGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for TNGX
Total Return (including Dividends) | TNGX | XBI | S&P 500 |
---|---|---|---|
1 Month | -19.15% | 2.02% | 2.87% |
3 Months | -58.24% | -15.44% | -6.42% |
12 Months | -85.33% | -14.02% | 9.87% |
5 Years | -88.86% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | TNGX | XBI | S&P 500 |
1 Month | -17.1% | 57% | 89.4% |
3 Months | -88.4% | -82.3% | -72% |
12 Months | -89.2% | -53.1% | 49.3% |
5 Years | -58.7% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #81 | -20.8% | -21.4% |
3 Month | #187 | -50.6% | -55.4% |
12 Month | #164 | -82.9% | -86.7% |
5 Years | #98 | -84.5% | -93.6% |
FAQs
Does TNGX Tango Therapeutics outperforms the market?
No,
over the last 12 months TNGX made -85.33%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months TNGX made -58.24%, while XBI made -15.44%.
Over the last 3 months TNGX made -58.24%, while XBI made -15.44%.
Performance Comparison TNGX vs Indeces and Sectors
TNGX vs. Indices TNGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -24.1% | -22.0% | -61.1% | -95.2% |
US NASDAQ 100 | QQQ | -24.3% | -23.9% | -61.5% | -96.7% |
US Dow Jones Industrial 30 | DIA | -24.4% | -20.8% | -60.1% | -91.7% |
German DAX 40 | DAX | -26.2% | -38.4% | -86.7% | -110% |
Shanghai Shenzhen CSI 300 | CSI 300 | -24.7% | -25.4% | -60.4% | -91.0% |
Hongkong Hang Seng | HSI | -27.6% | -35.4% | -70.6% | -97.4% |
India NIFTY 50 | INDA | -21.7% | -21.4% | -63.0% | -87.7% |
Brasil Bovespa | EWZ | -26.1% | -30.7% | -70.3% | -78.9% |
TNGX vs. Sectors TNGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -24.3% | -22.8% | -67.3% | -106% |
Consumer Discretionary | XLY | -25.0% | -22.7% | -58.9% | -99.4% |
Consumer Staples | XLP | -23.7% | -21.2% | -68.0% | -92.9% |
Energy | XLE | -25.1% | -19.2% | -55.1% | -75.6% |
Financial | XLF | -24.7% | -24.7% | -67.0% | -107% |
Health Care | XLV | -20.3% | -14.8% | -55.9% | -79.4% |
Industrial | XLI | -25.6% | -26.5% | -62.1% | -95.3% |
Materials | XLB | -24.1% | -23.9% | -57.1% | -79.3% |
Real Estate | XLRE | -23.7% | -25.3% | -63.5% | -98.8% |
Technology | XLK | -25.0% | -25.9% | -58.9% | -92.3% |
Utilities | XLU | -25.1% | -24.8% | -68.9% | -101% |
Aerospace & Defense | XAR | -24.6% | -28.5% | -70.4% | -110% |
Biotech | XBI | -16.0% | -21.2% | -40.1% | -71.3% |
Homebuilder | XHB | -23.6% | -22.2% | -47.5% | -75.6% |
Retail | XRT | -24.2% | -22.7% | -54.8% | -81.0% |